Pindolol excites dopaminergic and adrenergic neurons, and inhibits serotonergic neurons, by activation of 5-HT(1A) receptors

European Journal of Neuroscience

Volumn 12, Issue 9, 2000, Pages 3265-3275

  Lejeune, F ^a   Millan, M J ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

8 OH DPAT; Dorsal raphe nucleus; Locus coeruleus; Rat; Ventral tegmental area

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ADRENALIN; DOPAMINE; MONOAMINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PINDOLOL; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ADRENERGIC NERVE CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DORSAL RAPHE NUCLEUS; DOSE RESPONSE; DRUG ANTAGONISM; DRUG POTENTIATION; LIMBIC CORTEX; LOCUS CERULEUS; MALE; MOOD; NONHUMAN; PARABRACHIAL NUCLEUS; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SEROTONINERGIC NERVE CELL; VENTRAL TEGMENTUM;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ACTION POTENTIALS; ANIMAL; COMPARATIVE STUDY; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPINEPHRINE; LOCUS COERULEUS; MALE; NEURONS; PINDOLOL; PIPERAZINES; PYRIDINES; RAPHE NUCLEI; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; VENTRAL TEGMENTAL AREA;

EID: 0033804027     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2000.00222.x     Document Type: Article

References (100)

1. The rat 5-hydroxytryptamine(1B) receptor is the species homologue of the human 5-hydroxytryptamine(1Dβ) receptor
2. Evidence for a norepinephrine-mediated collateral inhibition of locus coeruleus neurons
3. Serotonergic and non-serotonergic neurons of the dorsal raphe: Reciprocal changes in firing induced by peripheral nerve stimulation
4. Increased dopamine turnover in the ventral striatum by 8-OH-DPAT administration in the rat
5. The 5-HT(1A) receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons
6. (R)-8-OH-DPAT preferentially increases dopamine release in the rat medial prefrontal cortex
7. Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT(1A) antagonists
8. Pindolol and (±)-tertatolol affect rat hippocampal 5-HT levels through mechanisms involving not only 5-HT(1A) but also 5-HT(1B) receptors
9. Relationship between locus coeruleus discharge rates and rates of norepinephrine release within neocortex as assessed by in vivo microdialysis
10. Current advances and trends in the treatment of depression
11. Agonist/antagonist interactions with cloned human 5-HT(1A) receptors: Variation in intrinsic activity studied in transfected HeLa neurones
12. Molecular biology of 5-HT receptors
13. 5-Hydroxytryptamine release in dorsal hippocampus of freely moving rats: Modulation by pindolol
14. The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotonergic neurons in rats is attenuated by lesions of the frontal cortex
15. Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systemically with (±)-8-hydroxy-2-(di-n-propylamino) tetralin
16. 2 receptor inhibition of calcium channels in acutely dissociated locus coeruleus neurones
17. Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT(1A) autoreceptor in vivo
18. Antagonist properties of pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT(1A) receptors in the rat brain
19. Electrophysiological evidence for a large receptor reserve for inhibition of dorsal raphe neuronal firing by 5-HT(1A) agonists
20. Evidence that 5-hydroxytryptamine release in rat dorsal raphe nucleus is controlled by 5-HT(1A), 5-HT(1B) and 5-HT(1D) autoreceptors
21. Selective blockade of serotonin(2C/2B) receptors enhances mesolimbic and mesocortical dopaminergic function: A combined in vivo electrophysiological and microdialysis study
22. Selective blockade of serotonin(2C/2B) receptors enhances dopamine release in the rat nucleus accumbens
23. 2 receptors: Microdialysis studies in the awake and anaesthetized rat
24. Citalopram and 8-OH-DPAT attenuate nicotine-induced excitation of central noradrenaline neurones
25. Pindolol suppresses serotonergic neuronal activity and does no block the inhibition of serotonergic neurones produced by 8-hydroxy-2-(di-n-propylamino) tetralin in awake cats
26. Enhanced norepinephrine release in prefrontal cortex with burst stimulation of the locus coeruleus
27. Pindolol increases extracellular 5-HT while inhibiting serotonergic neuronal activity
28. Antidepressants
29. Effects of (-)-tertatolol, (-)-penbutolol and (+)-pindolol in combination with paroxetine on presynaptic 5-HT function: An in vivo microdialysis and electrophysiological study
30. The selective 5-HT(1B) receptor inverse agonists 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl) biphenyl-4-yl]-2,3,6,7-tetrahydro-spiro[furo[2,3-f] indole-3-4'-piperidine]] (SB-224289) potently blocks termina 5-HT autoreceptor function both in vitro and in vivo
31. Modulation of dialysate levels of dopamine, noradrenaline and serotonin (5-HT) in the frontal cortex of freely-moving rats by pindolol alone and in association with 5-HT reuptake inhibitors: Comparative roles of β-adrenergic, 5-HT(1A) and 5-HT(1B) receptors
32. Serotonin (5-HT)(2A) receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rat
33. Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release
34. Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely-moving rats by combined blockade of 5-HT(1A) and 5-HT(1B) receptors with WAY 100,635 and GR 127,935
35. Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat
36. Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry
37. Selective serotonin reuptake inhibitors in affective disorders-II. Efficacy and quality of life
38. Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release
39. 7 receptor in rat brain
40. Effects of the alpha-2 adrenoceptor antagonist mirtazapine on the 5-hydroxytryotamine system in the rat brain
41. Modulation of the firing activity of adrenergic neurones in the rat locus coerleus by the 5-hydroxytryptamine system
42. Modulation of the firing activity of rat serotonin and noradrenaline neurones by (±) pindolol
43. + channel and 5-hydroxytryptamine(1A) autoreceptor interactions in the rat dorsal raphe nucleus: An in vitro electrophysiological study
44. Role of medial prefrontal cortex in 5-HT(1A) receptor-induced inhibition of 5-HT neuronal activity in the rat
45. Effect of 5-HT(1A) receptor ligands on Fos-like immunoreactivity in rat brain: Evidence for activation of adrenergic transmission
46. Influence of 5-HT(1A) receptors on central adrenergic activity; microdialysis studies using (±)-MDL 73005EF and its enantiomers
47. Serotonin(1A) receptor agonists induce Fos protein expression in the locus coeruleus of the conscious rat
48. Lack of 5-HT(1A) autoreceptor desensitisation following chronic citalopram treatment, as determined by in vivo microdialysis
49. Is pindolol a mixed agonist or antagonist at central serotonin (5-HT) receptors?
50. Effect of the 5-HT(1A) receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis
51. The effect of ipsapirone and S-piadolol on dopamine release in rat striatum and nucleus accumbens
52. Effects of 5-HT(1A) receptor antagonists on citalopram-induced increases in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus
53. 5-Hydroxytryptamine(1B) receptors block the GABA(B) synaptic potential in rat dopamine neurones
54. Comparison of effects of hypotension and handling stress on the release of noradrenaline and dopamine in the locus coeruleus and medial prefrontal cortex of the rat
55. An electrophysiological comparison of pindolol-induced changes in dorsal raphe nucleus neuronal activity in vivo and in vitro
56. 3 autoreceptors inhibits firing of ventral tegmental dopaminergic neurones in vivo
57. Induction of burst firing in ventral tegmental area dopaminergic neurones by activation of serotonin (5-HT)(1A) receptors: WAY-100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535
58. 2 and h serotonin(1A) receptors and their modulation of the activity of serotonergic and dopaminergic neurones in rats
59. Antidepressant-like behavioral effects of serotonin receptor agonists
60. Serotonin (5-HT) release in the dorsal raphe and ventral hippocampus: Raphe control of somatodendritic and terminal 5-HT release
61. Pindolol augmentation of antidepressant therapy
62. Receptor reserve for 5-hydroxytryptamine(1A)-mediated inhibition of serotonin synthesis: Possible relationship to anxiolytic properties of 5-hydroxytryptamine(1A) agonists
63. Effect of pindolol on hormone secretion and body temperature; partial agonist effects
64. Pindolol increases dialysate concentrations of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely-moving rats
65. Serotonin (5-HT)(2C) receptors tonically inhibit dopamine (DA) and noradrenaline (NAD), but not 5-HT, release in the frontal cortex in vivo
66. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)(1A) receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties
67. Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and adrenergic transmission in frontal cortex: A review, and relevance to the actions of antidepressant agents
68. S 14671: A naphthylpiperazine 5-hydroxytryptamine(1A) agonist of exceptional potency and high efficacy possessing antagonist activity at 5-HT(1C/2) receptors
69. 2 receptors in the rat brain
70. Agonist and antagonist actions of (-)pindolol at recombinant, human serotonin(1A) (5-HT(1A)) receptors
71. Involvement of beta-1 and beta-2 adrenergic receptors in the antidepressant-like effects of centrally administered isoproterenol
72. Burst firing in midbrain dopaminergic neurones
73. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT(1A) receptors that are negatively coupled to adenylate cyclase in permanently transfected HELA cells
74. 2+ current inhibition produced by serotonin in rat dorsal raphe neurones
75. Actions of 5-hydroxytryptamine on ventral tegmental area neurones of the rat in vitro
76. Excitation of adrenergic cell firing by 5-hydroxytryptamine1A agonists correlates with dopamine antagonist properties
77. Autoregulatory properties of dorsal raphe 5-HT neurones. Possible role of electronic coupling and 5-HT(1D) receptors in the rat brain
78. Autoregulation of serotonin neurones: Role in antidepressant drug action
79. Serotonin-dopamine interaction in the rat ventral tegmental area: An electrophysiological study in vivo
80. The role of hippocampal 5-hydroxytryptamine(1A) (5-HT(1A)) receptors in the anticonflict activity of β-adrenoceptor antagonists
81. Pindolol and major affective disorders: A three-year follow-up study of 30,485 patients
82. Displacement of the binding of 5-HT(1A) receptor ligands to pre- and postsynaptic receptors by (-) pindolol. A comparative study in rodent, primate and human brain
83. Effect of pindolol on the function of pre- and postsynaptic 5-HT(1A) receptors: In vivo microdialysis and electrophysiological studies in the rat brain
84. Development of new antidepressants
85. Assessment of relative efficacies of 5-HT(1A) receptor ligands by means of in vivo animal models
86. Ipsapirone and 1-(2-pyrimidinyl)-piperazine increase rat locus coeruleus adrenergic activity
87. Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone
88. Effect of a selective 5-HT reuptake inhibitor in combination, with 5-HT(1A) and 5-HT(1B) receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo
89. Drug interactions with 5-HT(1A) receptors
90. 2+ channels
91. Increase of noradrenaline release in the hypothalamus of freely moving rat by postsynaptic 5-hydroxytryptamine(1A) receptor activation
92. 2 receptor and α(1)-adrenoceptor antagonism
93. Anxiolytic 5-hydroxytryptamine (1A) agonists suppress firing activity of dorsal hippocampus CA1 pyramidal neurons through a postsynaptic mechanism: Single-unit study in unanesthetized, unrestrained rats
94. 7 receptors in guinea-pig brain
95. 1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino) tetralin in the rat
96. Dopaminergic neurones in the rat ventral tegmental area. I. Identification and characterization
97. Voltage- and ligand-activated inwardly rectifying currents in dorsal raphe neurones in vitro
98. Differentiation of 5-HT(1A) receptor ligands by drug discrimination
99. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine(1A) receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes